A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps

• Status: Completed
• Trial end date: 2011-11-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if intranasal Beclomethasone delivered by aerosol or spray is more effective in treatment of nasal polyps.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lawson Health Research Institute
• Treatments: Beclomethasone

Criteria

Inclusion Criteria:

• 18 years old

• New diagnosis of nasal polyps confirmed by two physicians

Exclusion Criteria:

• Intranasal corticosteroid use within 4 weeks

• Oral corticosteroids use within 4 weeks

• Oral corticosteroid inhalation (ie for treatment of asthma or COPD) of Budesonide >400ug daily, Fluticasone >250ug daily, Beclomethasone >400ug daily

• Contraindication to intranasal corticosteroid

• Inability to give informed consent

• Participation in another clinical trial

• Pregnancy (or not using effective method of contraception) or lactation

• Cystic fibrosis